Rilzabrutinib is a potent, reversible, and covalent Bruton's tyrosine kinase (BTK) inhibitor currently under investigation for the management of various immune-mediated diseases, including chronic spontaneous… Read more
![Chemical structure of (R)-3-(2-Fluoro-4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3105785-65-4-R-3-2-Fluoro-4-phenoxyphenyl-1-piperidin-3-yl-1H-pyrazolo34-dpyrimidin-4-amine-Hydrochloride.png&w=3840&q=75)



![Chemical structure of tert-Butyl (R)-3-(3-(2-fluoro-4-phenoxyphenyl)-4-((triphenyl-l5-phosphanylidene)amino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3105785-66-5-tert-Butyl-R-3-3-2-fluoro-4-phenoxyphenyl-4-triphenyl-l5-phosphanylideneamino-1H-pyrazolo34-dpyrimidin-1-ylpiperidine-1-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (R)-3-(3-iodo-4-((triphenyl-l5-phosphanylidene)amino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3072699-16-9-tert-Butyl-R-3-3-iodo-4-triphenyl-l5-phosphanylideneamino-1H-pyrazolo34-dpyrimidin-1-ylpiperidine-1-carboxylate.png&w=3840&q=75)

Rilzabrutinib is a potent, reversible, and covalent Bruton's tyrosine kinase (BTK) inhibitor currently under investigation for the management of various immune-mediated diseases, including chronic spontaneous urticaria and pemphigus. Laboratories utilize these high-purity reference standards for critical analytical tasks, including impurity profiling, method development, and rigorous quality control testing. The catalogue features the parent drug alongside its synthetic intermediates and related substances, which are essential for identifying degradation products and process-related impurities. Additionally, stable isotope labelled compounds are available to serve as precise internal standards for mass spectrometry applications. By utilizing these materials, researchers can ensure the accuracy of quantitative analyses and meet the stringent requirements for method validation throughout the drug development lifecycle, ensuring consistent safety and quality profiles.